Azra AI has acquired Blackford Analysis, an Edinburgh-based enterprise AI orchestration platform for medical imaging, from Sopris Capital for undisclosed terms. Sopris originally bought Blackford from Bayer on October 2. This marks Azra's second acquisition in under six months, following its purchase of Thynk Health.
Blackford's platform offers over 130 AI applications from more than 45 partner vendors, enabling health systems to evaluate, deploy, and manage AI imaging tools within existing workflows. The platform will be integrated into Azra's enterprise patient management system, which operates across oncology, radiology, cardiology, emergency medicine, and clinical research. Azra is deployed at more than 1,500 sites, including five of the top 10 U.S. health systems.
Since John Marshall became CEO in mid-2024, the company has grown 11x over 28 months. Marshall will lead the combined entity. The acquisition enhances Azra's ability to apply AI to medical images and guide confirmed findings through to patient care.
Source: PE Hub · Summarized by HeadlinesBriefing